Ovarian cancer study looks at key protein levels in tumor samples

NCT ID NCT07407062

Not yet recruiting Knowledge-focused Sponsor: AbbVie Source: ClinicalTrials.gov ↗

First seen Feb 24, 2026 · Last updated May 16, 2026 · Updated 12 times

Summary

This study looks at tissue samples from 200 people with relapsed ovarian, fallopian tube, or primary peritoneal cancer. Researchers want to see how often a protein called folate receptor alpha is found at high levels on tumor cells. No new treatments are given—the goal is simply to learn more about this protein in cancer that has come back.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER - OVARIAN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.